Educational research & price index · Independent Janoshik & MZ Biolabs COA verification
Guide|3 CitationsGLP-1 & MetabolicFemale-friendly

Tesofensine

Also known as: NS-2330, Triple Monoamine Reuptake Inhibitor, Oral Metabolic Compound

Dose Range
250–500 mcgResearch range
0Typical research window: 250–500 mcg600 mcg

Studied in published research — not a medical recommendation. Primary protocol (TIPO-1 Clinical Trial Oral Protocol): 250 mcg – 500 mcg (0.25 mg – 0.5 mg), Once daily in the morning (long ~8–9 day half-life).

Protocol at a Glance
How Often
Daily

Once daily in the morning (long ~8–9 day half-life)

A Typical Run
12–24 weeks

Research-reported range; the linked study used a different dose or units. Must be taken early in the morning due to its ~9-day plasma half-life

How It's Taken
Vial / Oral

Oral capsule/tablet

Evidence
Established

Human clinical trials or FDA-approved formulation exists

Half-Life & 72-Hour Clearance Shape
Not established

No verified human half-life on file for this compound

0h18h36h54h72h
On Your SyringeU-100 Insulin Syringe

A vial is powder until you add bacteriostatic water. Change the vial size or water volume below to see the exact unit mark on your syringe.

5 mg vial · 2 mL water · 0.3 mL syringe
Concentration: 2.5 mg in every mL (25 mcg per unit)
0u6u12u18u24u30u
Low end: 250 mcg10 units
High end: 500 mcg20 units

All U-100: 100 units = 1 mL. 20 doses in the vial at the low end (10 doses at the high end).

Track the doses you run

Save Tesofensine to your personal protocol list to log your custom dosage, syringe units, ON/OFF cycle dates, and lab notes across devices.

Verified Peptide Vial Suppliers · Sorted by Real $/mg•Checked Nov 11, 2026

Tesofensine supplier & $/mg comparison.

Source:
Max $/mg:
Sort:
Elite Research USA
Batch COA on product page
US Domestic Vial
List price
$90.00
10mg vial
$9.00/mg
Sorted strictly by calculated $/mg or 2026 COA score. Only research peptide vial suppliers are included in $/mg benchmarks.
Full Verified $/mg Index →

At a Glance · 2026 FDA / 503A / WADA / Evidence Profile

Phase 2/3 Clinical TrialsTier 2 — Human Phase 1/2 Clinical Data
Pharmacological Class
Oral Small-Molecule Metabolic & Nuclear Receptor Modulator
Administration Route
Oral capsule or liquid solution (Non-injectable small molecule)
2026 FDA & 503A Status
Active Phase 2/3 human clinical trials in 2026; not yet FDA-approved for commercial prescription or 503A bulk pharmacy compounding. Sold strictly as an analytical laboratory reference standard.
WADA Sport Status
Prohibited at All Times (WADA S0 Unapproved Substances & S2.2 Peptide Hormones, Growth Factors & Mimetics)
Evidence Tier
Tier 2 — Human Phase 1/2 Clinical Data: Published human Phase 1/2 clinical studies, regional regulatory approval, or controlled human biomarker trials

Bottom Line Up Front

Tesofensine (NS-2330) is an oral phenyltropane small molecule (not a peptide) that inhibits the presynaptic reuptake of dopamine, norepinephrine, and serotonin. Phase 2 human trials (TIPO-1, Lancet) demonstrated ~10.6% weight loss in 24 weeks at 0.5 mg/day via central appetite suppression and increased resting thermogenesis.

Best evidence for

Published preclinical & translational clinical protocols

Weakest evidence for

Large multi-year outcomes in healthy non-clinical cohorts

Pharma equivalent

None

Studies on file

3 (0 human)

EDUCATIONAL AND RESEARCH REFERENCE ONLY — NOT MEDICAL ADVICE. Tesofensine is not FDA approved for human use (unless specified above). This information does not constitute medical advice.

Overview

Tesofensine is a centrally acting triple monoamine neurotransmitter reuptake inhibitor (SNDRI) originally investigated for neurodegenerative conditions before researchers observed consistent, dose-dependent weight loss. In the landmark Phase 2 TIPO-1 randomized trial published in The Lancet, 0.5 mg once daily produced nearly double the weight loss of previously approved oral anti-obesity agents while preserving mood and motivation during caloric restriction.

Mechanisms of Action

  • Inhibits presynaptic reuptake of norepinephrine, dopamine, and serotonin in hypothalamic satiety centers
  • Stimulates alpha-1 adrenoceptor and D1 dopamine receptor pathways to reduce hunger and food cravings
  • Increases nocturnal fat oxidation and 24-hour energy expenditure (~6% increase in human calorimeter studies)

Research Protocols

Summaries of published research. For educational purposes only.

Protocol NameSourceDoseFrequencyDurationRouteEvidenceLinkSave
TIPO-1 Clinical Trial Oral Protocol
reported protocol
250 mcg – 500 mcg (0.25 mg – 0.5 mg)Once daily in the morning (long ~8–9 day half-life)12–24 weeksOral capsule/tabletclinical trial
Baseline & Mid-Cycle Biomarker Bloodwork Panel

Metabolic, Hepatic & Incretin Safety Biomarker Panel (Tesofensine)

Quantify visceral fat mobilization, insulin resistance reversal, hepatic steatosis (MASH) clearance, and pancreatic/renal safety during metabolic protocols.

Draw fasted morning labs at Baseline (Day 0) and Mid-Cycle (Week 6–8)

HbA1c & Fasting Insulin (HOMA-IR)

Day 0 + Wk 6–8

Why track at baseline: Measures baseline hyperinsulinemia and 90-day glycemic load prior to incretin or lipolytic initiation.

Week 6–8 check: Track rapid drop in Fasting Insulin (often 30%–50% reduction by Week 6–8) and normalizing HbA1c.

ALT, AST & GGT Liver Enzymes

Day 0 + Wk 6–8

Why track at baseline: Dual/triple agonists (Retatrutide, Mazdutide, Pemvidutide) mobilize 65%–80% of intrahepatic triglycerides.

Week 6–8 check: Confirm progressive reduction in ALT/AST (<25 U/L) as hepatic steatosis clears.

ApoB, Triglycerides & Advanced Lipid Panel

Day 0 + Wk 6–8

Why track at baseline: Quantifies atherogenic particle burden and VLDL triglyceride export before weight loss.

Week 6–8 check: Expect 20%–40% triglyceride drop and significant ApoB improvement alongside visceral fat loss.

Serum Lipase, Amylase & eGFR / Cystatin C

Day 0 + Wk 6–8

Why track at baseline: Essential safety screen for subclinical pancreatic inflammation and hydration/renal filtration.

Week 6–8 check: Ensure Lipase stays within reference range and eGFR remains stable with adequate electrolyte hydration.

Test before and during your protocol: one baseline panel of 100+ Quest biomarkers covering the markers above, plus a mid-cycle retest. No doctor visit required.Code SPAMBASSADOR
Get baseline bloodwork at Superpower

Community Outcomes

Community Data Coming Soon

Aggregate community outcomes will be displayed here once we have more reports. Be one of the first to share your experience!

Outcomes are self-reported and unverified. They represent individual experiences and may not reflect typical results.

Important Warnings

  • •Do NOT combine with SSRIs, SNRIs, MAOIs, or high-dose stimulants (serotonin/sympathomimetic interaction risk)
  • •Monitor resting heart rate and blood pressure (1.0 mg doses in trials elevated HR by ~7–8 bpm; 0.25–0.5 mg is preferred)
Sourcing, Diagnostic Bloodwork & Telehealth Pathways

Where to get Tesofensine, baseline labs & clinician oversight.

Full Tesofensine $/mg comparison →
50% OFF AUTO-APPLIEDFrom $0.30/mg net

Ascension Peptides (US Vials)

MZ Biolabs & SafeCert COA-verified US domestic single vials with 50% off auto-applied for new customers.

MZ Biolabs COA (Grade A)Claim 50% Off
Verified Vial SuppliersGrade A COA

SwissChems & Limitless Biotech

Same-day US domestic lyophilized vials, oral capsules, and endotoxin-screened nasal sprays (15% off Limitless w/ code PEPTIDEPROTOCOLS).

LABS & 503A CLINICS$199/yr Labs · Rx Consult

Superpower Labs & 503A Telehealth

Bloodwork, not a vial store. Get a baseline panel (100+ Quest biomarkers: metabolic, lipids, hormones, inflammation, kidney/liver) before you start a peptide protocol, then retest mid-cycle to see what actually changed.

Code:SPAMBASSADOR

Where to buy Tesofensine: best verified price

Prices checked Nov 11, 2026 · sorted by $/mg · RUO

  1. 1. Elite Research USA — $9.00/mg (10mg vial, $90.00)

Where is the cheapest place to buy Tesofensine?

As of Nov 11, 2026, the lowest verified US domestic single-vial price we found is Elite Research USA at $9.00/mg (10mg vial, $90.00). We compared 1 US supplier with live, checked prices.

How much does Tesofensine cost per mg?

Verified US domestic prices currently range from $9.00/mg to $9.00/mg depending on supplier and vial size. Larger vials usually lower the $/mg.

How are these prices verified?

Each price is read from the supplier's own product page or store data and divided by the vial's mg. Suppliers we could not verify are left out rather than estimated. Tables sort strictly by $/mg, never by partner status. Prices are re-checked weekly on our price index.

Is Tesofensine approved for human use?

Products from these suppliers are sold for laboratory research use only (RUO). This page is an educational price reference, not medical advice.

All compounds $/mgWeekly $/mg price indexReconstitution calculatorFree cheat sheet

FREE 1-PAGE PDF CHEAT SHEET

Peptide Reconstitution & U-100 Syringe Cheat Sheet

Printable U-100 insulin syringe draw chart for 5mg–50mg vials, plus our weekly $/mg price-drop brief.

Unsubscribe anytime.Direct PDF Download

Related Peptides

Vendor vs vendor: price per mg

Head-to-head $/mg on shared compounds. Prices verified Nov 11, 2026.

Compound vs compound: BPC-157 vs TB-500 · Tirzepatide vs Semaglutide · Retatrutide vs Tirzepatide · Wolverine Blend vs GLOW Blend · Semax vs Selank · KLOW Blend vs GLOW Blend · MOTS-c vs SS-31 · Sermorelin vs Ipamorelin · Retatrutide vs Semaglutide · Tesamorelin vs Sermorelin · All compounds $/mg →

Common questions

How many peptides are in the database?

100 compound pages, each with dosing references, reconstitution math and price per mg where a verified vendor price exists.

Where can I compare peptide prices?

Each compound page shows verified $/mg by vendor; the vendor-vs-vendor pages above compare two vendors across their shared compounds.